×
UK
regions
International
regions
Venue
hire
Log in to
MyRCPath
Close
Favourites
Search
Menu
Discover
PATHOLOGY
What is pathology?
Careers in pathology
Events
Resources
Competitions
Membership
Undergraduates and Foundation doctors
News
Blogs
Public affairs
Videos
Pathologists in Profile Podcast Series
Diamond Jubilee
For
Trainees
COVID-19: information for trainees
Training
Webinars: What I Wish I’d Known
Assessment
Examinations
Cost of training
Preparing to be a new consultant
For the
Profession
On the agenda
College responses
SAS Doctors
Clinical Impact Awards
Patient safety and quality improvement
Coronavirus: COVID-19 resources hub
Conferences
Continuing Professional Development (CPD)
Appraisal and revalidation
Guidelines
Publications
Workforce planning
Workforce data
Employing pathologists
Digital pathology
Committees
RCPath Consulting
Research and innovation
Medical examiners
Training standards
Pathology Portal
Equality, diversity and inclusion
Member engagement
In your
Specialist area
Cellular pathology
Clinical biochemistry
Microbiology
Haematology
Transfusion medicine
Neuropathology
Paediatric and perinatal pathology
Oral and maxillofacial pathology
Reproductive science
Forensic pathology
Toxicology
Histocompatibility and immunogenetics
Virology
Immunology
Genetics
Molecular pathology
Veterinary pathology
About the College
Document library
UK
regions
International
regions
Venue
hire
Log in to MyRCPath
Homepage
Document library
Aurora Kinase A (AURKA) is a Predictor of Recurrence in Breast Ductal Carcinoma in situ (DCIS)
Aurora Kinase A (AURKA) is a Predictor of Recurrence in Breast Ductal Carcinoma in situ (DCIS)
Aurora Kinase A (AURKA) is a Predictor of Recurrence in Breast Ductal Carcinoma in situ (DCIS)
More resources
